Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cerespan
2. Hydrochloride, Papaverine
3. Papaverine
4. Pavabid
5. Pavatym
1. 61-25-6
2. Cardoverina
3. Cardiospan
4. Papaversan
5. Artegodan
6. Forpavin
7. Papalease
8. Pavatest
9. Pavabid
10. Dispamil
11. Drapavel
12. Paverolan
13. Alapav
14. Cerebid
15. Delapav
16. Dilaves
17. Durapav
18. Dynovas
19. Myobid
20. Pameion
21. Papacon
22. Pavacap
23. Pavacen
24. Paveron
25. Pavnell
26. Vasal
27. Papaverine Hcl
28. Ro-papav
29. Vaso-pav
30. 1-(3,4-dimethoxybenzyl)-6,7-dimethoxyisoquinoline Hydrochloride
31. Cerespan
32. Papaverinium Chloride
33. Papanerin-hcl
34. Papavarine Chlorhydrate
35. Pap-kaps-150
36. Papaverine Chlorohydrate
37. Papaverine, Hcl
38. Pap H
39. Papaverine (hydrochloride)
40. Papaverine Monohydrochloride
41. Nci-c56359
42. Vasorin
43. Chlorhydrate De Papaverine
44. Nsc 35443
45. 6,7-dimethoxy-1-veratrylisoquinoline Hydrochloride
46. Nsc-35443
47. Mls000028497
48. 23473ec6bq
49. Cepaverin
50. Optenyl
51. Pavagrant
52. Pavakey
53. Pavased
54. Smr000058283
55. Therapav
56. Dipav
57. Lapav
58. Dsstox_cid_5825
59. Spasmo-nit
60. Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-, Hydrochloride
61. Dsstox_rid_77939
62. Dsstox_gsid_25825
63. Papanerin-hcl [german]
64. 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline;hydrochloride
65. Nsc35443
66. Ccris 3804
67. Cas-61-25-6
68. Sr-01000003098
69. Chlorhydrate De Papaverine [french]
70. Ncgc00015810-02
71. Einecs 200-502-1
72. Pamelon
73. Unii-23473ec6bq
74. Papaverine Hydrochloride [jan]
75. Qua Bid
76. Prestwick_376
77. Papaverine Hydrochloride [usp:jan]
78. Pavabid (tn)
79. Component Of Copavin
80. Mfcd00012745
81. Isoquinoline, 6,7-dimethoxy-1-veratryl-, Hydrochloride
82. 6,7,3',4'-tetramethoxy-1-benzylisoquinoline Hydrochloride
83. Papaverini Hydrochloridum
84. Papaverine, Hydrochloride
85. Opera_id_1617
86. Regid_for_cid_6084
87. Mls001148655
88. Mls002222208
89. Chembl98123
90. Schembl121268
91. Spectrum1500459
92. Papaverine Hydrochloride, Powder
93. Dtxsid9025825
94. Cas 61-25-6
95. Hms1569f08
96. Hms1920f06
97. Pharmakon1600-01500459
98. Tox21_110226
99. Tox21_500957
100. Ccg-40065
101. Hy-18077a
102. Nsc757256
103. Papaverine Hydrochloride [mi]
104. Papaverine Hydrochloride (jp17/usp)
105. Akos005111070
106. Tox21_110226_1
107. Cs-5015
108. Lp00957
109. Nsc-757256
110. Papaverine Hydrochloride [hsdb]
111. Papaverine Hydrochloride [mart.]
112. Papaverine Hydrochloride [vandf]
113. Ncgc00015810-12
114. Ncgc00094258-01
115. Ncgc00094258-02
116. Ncgc00094258-03
117. Ncgc00094258-04
118. Ncgc00094258-05
119. Ncgc00094258-06
120. Ncgc00261642-01
121. Papaverine Hydrochloride [usp-rs]
122. Papaverine Hydrochloride [who-dd]
123. Papaverine Hydrochloride [who-ip]
124. As-13262
125. 1-(3,7-dimethoxyisoquinoline Hydrochloride
126. Db-053821
127. Eu-0100957
128. P0016
129. D02218
130. D86684
131. P 3510
132. Papaverine Hydrochloride [ep Monograph]
133. Papaverine Hydrochloride [usp Monograph]
134. Papaverini Hydrochloridum [who-ip Latin]
135. Isoquinoline,7-dimethoxy-1-veratryl-, Hydrochloride
136. Sr-01000003098-2
137. Sr-01000003098-4
138. Sr-01000003098-9
139. Wln: T66 Cnj B1r Co1 Do1& Ho1 Io1 &gh
140. Q27253713
141. Sr-01000003098-11
142. 6,3',4'-tetramethoxy-1-benzylisoquinoline Hydrochloride
143. 1-(3,4-dimethoxybenzyl)-6,7-dimethoxyisoquinolinehydrochloride
144. Isoquinoline,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-, Hydrochloride
145. Papaverine Hydrochloride, British Pharmacopoeia (bp) Reference Standard
146. Papaverine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
147. Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-, Hydrochloride (1:1)
148. Papaverine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
149. Papaverine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 375.8 g/mol |
---|---|
Molecular Formula | C20H22ClNO4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 375.1237359 g/mol |
Monoisotopic Mass | 375.1237359 g/mol |
Topological Polar Surface Area | 49.8 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 407 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Phosphodiesterase Inhibitors
Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2426
Submission : 1975-03-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3633
Submission : 1979-10-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3309
Submission : 1978-06-15
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1006
Submission : 1966-11-04
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 830
Submission : 1964-08-27
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 822
Submission : 1964-07-02
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3863
Submission : 1980-07-03
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Registration Number : 231MF10018
Registrant's Address : VIA M. Civitali, 1-20148 MILANO, ITALY
Initial Date of Registration : 2019-01-29
Latest Date of Registration : 2019-01-29
Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.
Papaverine hydrochloride BP/EP/USP
Date of Issue : 2021-06-03
Valid Till : 2024-02-07
Written Confirmation Number : WC-301n
Address of the Firm : Plot No 60A, Jawaharlal Nehru Pharma City, Parawada Mandal, Vishakhapatnam, Andh...
Date of Issue : 2021-08-27
Valid Till : 2022-08-13
Written Confirmation Number : WC-0171A3
Address of the Firm : (Unit-III), Village-Bhagwanpur, Barwala Road, Derabassi, Dist-Mohali (Punjab)
Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.
About the Company : Synnat Pharma is a fast-growing pharmaceutical company dedicated to the identification, development, production and distribution of potent phytochemicals and botanical extracts. AP...
About the Company : Established in 1997, Temad Co. is one of the largest producers of APIs in Iran & an innovative manufacturer of narcotic and non-narcotic products of world-class quality in the Midd...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering g...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs)...
About the Company : Parand Daro Pharmaceutical Company is a knowledge-based company that commenced operations in 2015, focusing on the production of narcotic medicinal substances. Parand Daro holds th...
About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...
About the Company : Inga Pharmaceuticals (Inga), established in 1980, is involved in the cultivation, isolation and extraction of actives from plant sources. The Corporate Office is located in Mumbai ...
About the Company : Established in 1995, Kimyagaran Emrooz Chemical Industries Co. is recognized as one of the major leading production enterprises in the ethoxylation and propoxylation industry for m...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Papaverine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Papaverine, including repackagers and relabelers. The FDA regulates Papaverine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Papaverine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Papaverine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Papaverine supplier is an individual or a company that provides Papaverine active pharmaceutical ingredient (API) or Papaverine finished formulations upon request. The Papaverine suppliers may include Papaverine API manufacturers, exporters, distributors and traders.
click here to find a list of Papaverine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Papaverine DMF (Drug Master File) is a document detailing the whole manufacturing process of Papaverine active pharmaceutical ingredient (API) in detail. Different forms of Papaverine DMFs exist exist since differing nations have different regulations, such as Papaverine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Papaverine DMF submitted to regulatory agencies in the US is known as a USDMF. Papaverine USDMF includes data on Papaverine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Papaverine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Papaverine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Papaverine Drug Master File in Japan (Papaverine JDMF) empowers Papaverine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Papaverine JDMF during the approval evaluation for pharmaceutical products. At the time of Papaverine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Papaverine suppliers with JDMF on PharmaCompass.
A Papaverine written confirmation (Papaverine WC) is an official document issued by a regulatory agency to a Papaverine manufacturer, verifying that the manufacturing facility of a Papaverine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Papaverine APIs or Papaverine finished pharmaceutical products to another nation, regulatory agencies frequently require a Papaverine WC (written confirmation) as part of the regulatory process.
click here to find a list of Papaverine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Papaverine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Papaverine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Papaverine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Papaverine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Papaverine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Papaverine suppliers with NDC on PharmaCompass.
Papaverine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Papaverine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Papaverine GMP manufacturer or Papaverine GMP API supplier for your needs.
A Papaverine CoA (Certificate of Analysis) is a formal document that attests to Papaverine's compliance with Papaverine specifications and serves as a tool for batch-level quality control.
Papaverine CoA mostly includes findings from lab analyses of a specific batch. For each Papaverine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Papaverine may be tested according to a variety of international standards, such as European Pharmacopoeia (Papaverine EP), Papaverine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Papaverine USP).
LOOKING FOR A SUPPLIER?